GERIATRIC ASSESSMENT-DRIVEN POLYPHARMACY DISCUSSIONS BETWEEN ONCOLOGISTS OLDER PATIENTS AND THEIR CAREGIVERS

摘要

ObjectivesPolypharmacy (PP) and potentially inappropriate medications (PIM) are common in older adults with cancer, increasing the risk of adverse outcomes. Approaches to identifying and addressing PP/PIM are needed.